Quinolinic acid was first identified in uremic serum by use of gas chromatography/mass spectrometry. Quantification by selected ion monitoring revealed that the serum concentration of quinolinic acid was markedly increased in the chronic hemodialysis patients, and that the acid could be removed by conventional hemodialysis. The serum concentration of quinolinic acid was weakly but significantly correlated with the serum uric acid concentration. Accumulation of quinolinic acid in uremic blood may be involved in the pathogenesis of anemia, suppressed immune system, and uremic encephalopathy. To our knowledge, however, there has been no report on quantifying quinolinic acid in serum of uremic patients.
Quinolinic acid was first identified in uremic serum by use of gas chromatography/mass spectrometry. Quantification by selected ion monitoring revealed that the serum concentration of quinolinic acid was markedly increased in the chronic hemodialysis patients, and that the acid could be removed by conventional hemodialysis. The serum concentration of quinolinic acid was weakly but significantly correlated with the serum uric acid concentration. Accumulation of quinolinic acid in uremic blood may be involved in the pathogenesis of anemia, suppressed immune system, and uremic encephalopathy. To our knowledge, however, there has been no report on quantifying quinolinic acid in serum of uremic patients.
In this study we identified and quantified quinolimc acid in uremic serum by GC/MS to determine the possible pathogenetic role of quinolinic acid in hemodialysis (HD) patients.
Materials and Methods

Chemicals
Quinolinic acid and 3,5-pyridinedicarboxylic acid were purchased from Tokyo Kasei Co., Tokyo, Japan. 
Department
Subjects
The study included 54 patients receiving HD, 4 h three times a week. They had been undergoing periodic dialysis for 5.4 (SD 4.4) years (range 0.3-16.3 years). Their mean age was 53.9 (SD 11.7) years (range 26-78 years); 31 were men and 23 were women. Blood samples were taken before and after liD and allowed to clot. The controls were a group of 10 healthy subjects, five of each sex. All serum samples were stored at -20 #{176}C until they were analyzed.
Sample Preparation for GC/MS
After addition of 30 nmol of 3,5-pyridinedicarboxylic acid as an internal standard,
mL of serum was
deproteinized with 2 mL of ethanol. After centrifugation at 1500 x g for 15 mm, the supernate was collected, then evaporated in a rotary evaporator. The residue was dissolved with 1 mL of distilled water. The Bond Elut SAX column was pre-activated with 1 mL of 0.5 mollL HCI reagent, washed with 1 mL of methanol, and further washed with 2 mL of distilled water. The dissolved residue was applied to the pretreated column, and the acids were eluted with 1 mL of 0.5 mol/L HC1 reagent. The eluate was evaporated in a rotary evaporator. The extract residue was methylated with diazomethane in ether at room temperature for 30 mm. After evaporating the derivative under a nitrogen stream, we dissolved the sample in 20 L of an equivolume solution of rnethanollchloroform, then injected 2 pL of this into the GCIMS.
To extract quinolinic acid not bound to serum protein, we deproteinized serum with a cone membrane filter (CF-25; Arnicon, Lexington, MA) after addition of 30 nmol of 3,5'-pyridinedicarboxylic acid as an internal standard. The ultraiiltrate was applied to the pretreated Bond Elut SAX column and treated in the same way as the supernate of the ethanol-deproteinized serum.
GC/MS
The methylated sample was analyzed with a movingneedle injection system of a Model GC-9A gas chromatograph combined with a double-focusing mass spectrometer (Model 9020-DF; both from Shixnadzu, Tokyo, Japan). The data were stored and processed in a Shimadzu PAC-1100 data processing system. The GC column was The correlation coefficient of the calibration line for quinolinic acid, y = 8.Ox + 2.1, was 0.9999.
There were no interfering peaks in the SIM chromatograms of the serum samples for assay of quinolinic acid. roisopropanol ester (7, 8) , because methylation with diazomethane is easy to perform, even at room temperature. All data are expressed as mean ± SD. Statistical analysis was by Student's t-test. Figure 2 shows the gas chromatogram of methylated acids extracted from ethanol-deproteinized uremic serum. The El mass spectrum of a peak in the gas chromatogram is shown in Figure 3b . We identified the peak as quinolinic acid dimethyl ester, because its retention time (8.7 mm) and El mass spectrum ( Figure  3b) were identical with those of authentic quinolinic acid dimethyl ester (Figure 3a) .
Results
Identification of quinolinic acid in uremic serum by GC/MS.
Quantification of quinolinic
acid in uremic serum. Figure 4 shows the SIM acid accumulated in the uremic serum was not bound to serum protein, because the acid was detected in the uremic serum ultrafiltrate (9.0 ± 3.0 pmolJL, n = 10) at the same concentration as in the ethanol-deproteinized uremic serum (9.0 ± 2.9 /.LmolJL, n = 10). Therefore, the protein binding of quinolinic acid in uremic serum was 0%. Table 1 shows the concentrations of quinolinic acid in serum samples of chronic HD patients. The mean concentration of quinolinic acid in the pre-HD serum of uremic patients was about 15-fold greater than that in healthy subjects. To determine the rate of removal of quinolinic acid by HD, we quantified the concentration of quinolinic acid in serum samples taken before and after HD. The decrease was as great as 83%, indicating the good dialyzability of the acid. The serum concentration of quinolimc acid in the uremic patients showed a weak but significant correlation with the serum concentration of uric acid (r = 0.298, P <0.05).
DIscussIon
Quinolinic acid reportedly suppresseserythroid colony formation and lymphocyte blast formation even at 6.0 pmol/L (5), which is comparable with its concentra- Quinolinic acid may be involved in a dysfunction of immune system in uremic patients through its inhibitory effect on lymphocyte blast formation. Qumnolinic acid is also reported to inhibit the binding of phenytoin to bovine serum albumin (5) . However, our study indicated that quinolinic acid in serum was not bound to serum 
